Noriko Ban

1.0k total citations
24 papers, 848 citations indexed

About

Noriko Ban is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Noriko Ban has authored 24 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Noriko Ban's work include Cardiovascular Health and Disease Prevention (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Blood Pressure and Hypertension Studies (4 papers). Noriko Ban is often cited by papers focused on Cardiovascular Health and Disease Prevention (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Blood Pressure and Hypertension Studies (4 papers). Noriko Ban collaborates with scholars based in Japan, Australia and United States. Noriko Ban's co-authors include Atsuhito Saiki, Hidetoshi Kawana, Takashi Yamaguchi, Masahiro Ohira, Daiji Nagayama, Kei Endo, Tomokazu Oyama, Kohji Shirai, Yoh Miyashita and Ayako Nagumo and has published in prestigious journals such as European Heart Journal, Atherosclerosis and Metabolism.

In The Last Decade

Noriko Ban

24 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noriko Ban Japan	17	568	282	188	113	105	24	848
Hidetoshi Kawana Japan	16	598 1.1×	264 0.9×	164 0.9×	92 0.8×	114 1.1×	27	825
Masahiro Ohira Japan	23	761 1.3×	438 1.6×	334 1.8×	186 1.6×	152 1.4×	64	1.3k
Enrico Agabiti Rosei Italy	19	724 1.3×	178 0.6×	290 1.5×	57 0.5×	61 0.6×	32	994
Claudia Agabiti-Rosei Italy	15	515 0.9×	267 0.9×	158 0.8×	87 0.8×	89 0.8×	27	889
Daiji Nagayama Japan	21	1.0k 1.8×	451 1.6×	267 1.4×	118 1.0×	222 2.1×	67	1.5k
Sion Roy United States	13	329 0.6×	351 1.2×	144 0.8×	85 0.8×	92 0.9×	75	860
Tomokazu Oyama Japan	21	649 1.1×	422 1.5×	396 2.1×	179 1.6×	124 1.2×	36	1.3k
Shauna Hurley United States	5	753 1.3×	238 0.8×	372 2.0×	99 0.9×	181 1.7×	6	1.1k
Chen Chi China	15	402 0.7×	103 0.4×	202 1.1×	115 1.0×	134 1.3×	49	753
Alessandro Mengozzi Italy	17	454 0.8×	177 0.6×	200 1.1×	199 1.8×	45 0.4×	50	1.0k

Countries citing papers authored by Noriko Ban

Since Specialization

Citations

This map shows the geographic impact of Noriko Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Ban more than expected).

Fields of papers citing papers by Noriko Ban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Ban. The network helps show where Noriko Ban may publish in the future.

Co-authorship network of co-authors of Noriko Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Ban. A scholar is included among the top collaborators of Noriko Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Ban. Noriko Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohira, Masahiro, Yasuhiro Watanabe, Shoko Nakamura, et al.. (2021). Association of Plasma Xanthine Oxidoreductase with Arterial Stiffness in Type 2 Diabetes with Liver Dysfunction. The American Journal of the Medical Sciences. 363(3). 242–250. 5 indexed citations

Imamura, Haruki, Daiji Nagayama, Noriko Ishihara, et al.. (2017). Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes. Molecular Genetics and Metabolism Reports. 12. 44–50. 40 indexed citations

Shimizu, Naomi, Noriko Ban, Yasuhiro Watanabe, et al.. (2017). The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone. Journal of Clinical Medicine Research. 9(8). 729–732. 6 indexed citations

Watanabe, Yasuhiro, Naomi Shimizu, Takashi Yamaguchi, et al.. (2017). Successful Treatment of Rapidly Progressive Life-Threatening Esophageal Submucosal Hematoma in a Patient With van der Hoeve Syndrome. Journal of Clinical Medicine Research. 10(2). 154–157. 1 indexed citations

Watanabe, Yasuhiro, Takashi Yamaguchi, Noriko Ishihara, et al.. (2017). 7-Ketocholesterol induces ROS-mediated mRNA expression of 12-lipoxygenase, cyclooxygenase-2 and pro-inflammatory cytokines in human mesangial cells: Potential role in diabetic nephropathy. Prostaglandins & Other Lipid Mediators. 134. 16–23. 22 indexed citations

Nagayama, Daiji, Haruki Imamura, Yuta Sato, et al.. (2016). Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study. Vascular Health and Risk Management. Volume 13. 1–9. 42 indexed citations

Nagayama, Daiji, Rena Watanabe, Yasuhiro Watanabe, et al.. (2016). OS 10-04 INVERSE RELATIONSHIP BETWEEN CARDIO-ANKLE VASCULAR INDEX (CAVI) AND BODY MASS INDEX IN HEALTHY JAPANESE SUBJECTS. Journal of Hypertension. 34(Supplement 1). e73–e73. 3 indexed citations

Nagayama, Daiji, Takashi Yamaguchi, Atsuhito Saiki, et al.. (2015). High serum uric acid is associated with increased cardio-ankle vascular index (CAVI) in healthy Japanese subjects: A cross-sectional study. Atherosclerosis. 239(1). 163–168. 40 indexed citations

Saiki, Atsuhito, Yuta Sato, Rena Watanabe, et al.. (2015). The Role of a Novel Arterial Stiffness Parameter, Cardio-Ankle Vascular Index (CAVI), as a Surrogate Marker for Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis. 23(2). 155–168. 78 indexed citations

10.

Ohira, Masahiro, Takashi Yamaguchi, Noriko Ban, et al.. (2014). Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus. Clinical and investigative medicine. 37(4). E243–E251. 12 indexed citations

11.

Ohira, Masahiro, Takashi Yamaguchi, Atsuhito Saiki, et al.. (2014). Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. Diabetes Metabolic Syndrome and Obesity. 7. 313–313. 26 indexed citations

12.

Endo, Kei, Atsuhito Saiki, Takashi Yamaguchi, et al.. (2013). Probucol Suppresses Initiation of Chronic Hemodialysis Therapy and Renal Dysfunction-Related Death in Diabetic Nephropathy Patients: Sakura Study. Journal of Atherosclerosis and Thrombosis. 20(5). 494–502. 18 indexed citations

13.

Nagayama, Daiji, Kei Endo, Masahiro Ohira, et al.. (2011). Effects of body weight reduction on cardio-ankle vascular index (CAVI). Obesity Research & Clinical Practice. 7(2). e139–e145. 59 indexed citations

14.

Miyashita, Yoh, Kei Endo, Atsuhito Saiki, et al.. (2010). Effect of Ezetimibe Monotherapy on Lipid Metabolism and Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Type 2 Diabetic Patients. Journal of Atherosclerosis and Thrombosis. 17(10). 1070–1076. 33 indexed citations

15.

Ohira, Masahiro, Kei Endo, Tomokazu Oyama, et al.. (2010). Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70. Metabolism. 60(1). 78–85. 40 indexed citations

16.

Nagayama, Daiji, Atsuhito Saiki, Kei Endo, et al.. (2010). Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. International Journal of Clinical Practice. 64(13). 1796–1801. 63 indexed citations

17.

Saiki, Atsuhito, Kei Endo, Noriko Ban, et al.. (2009). Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy. Journal of Atherosclerosis and Thrombosis. 16(5). 568–575. 58 indexed citations

18.

Miyashita, Yoh, Atsuhito Saiki, Kei Endo, et al.. (2009). Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension. Journal of Atherosclerosis and Thrombosis. 16(5). 621–626. 62 indexed citations

19.

Endo, Kei, Tomokazu Oyama, Atsuhito Saiki, et al.. (2008). Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus. Diabetes Research and Clinical Practice. 80(1). 63–68. 41 indexed citations

20.

Oyama, Tomokazu, Atsuhito Saiki, Noriko Ban, et al.. (2008). Effect of Acarbose, an Alpha-Glucosidase Inhibitor, on Serum Lipoprotein Lipase Mass Levels and Common Carotid Artery Intima-Media Thickness in Type 2 Diabetes Mellitus Treated by Sulfonylurea. Journal of Atherosclerosis and Thrombosis. 15(3). 154–159. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact